Dapaease - V 10MG SR Tab

Composition

Dapagliflozin 10 mg (as dapagliflozin propanediol monohydrate) + Vildagliptin (strength unknown) (Sustained release)

Uses of Dapaease - V 10MG SR Tab

Type 2 diabetes mellitus: adjunct to diet and exercise to improve glycaemic control when dual therapy with an SGLT2 inhibitor and a DPP-4 inhibitor is appropriate.

• •Lowers blood sugar (HbA1c) in type 2 diabetes
• •Improves fasting and post‑meal glucose control
• •Low risk of hypoglycaemia when used without insulin/sulfonylureas
• •May aid modest weight reduction with dapagliflozin

How it works

Dapagliflozin (SGLT2 inhibitor) lowers blood glucose by increasing urinary glucose excretion via the kidneys. Vildagliptin (DPP-4 inhibitor) increases incretin levels, enhancing glucose-dependent insulin release and reducing glucagon secretion. Together they improve fasting and post‑meal glucose control with a low risk of hypoglycaemia when not used with insulin/sulfonylureas.

Directions for use

Tablet (SR): take exactly as prescribed, usually once daily; swallow whole without crushing/chewing. Can be taken with or without food (preferably at the same time each day). Maintain adequate hydration; monitor blood sugar regularly.

Side effects

Common side effects of Dapaease - V 10MG SR Tab may include:

• •Genital fungal infection
• •urinary tract infection
• •increased urination